IL-2 plus GLP-1 RA Combination Therapy to Target Inflammation in AD
Description: <b id="docs-internal-guid-65247f69-7fff-3134-3792-5e9d6e552334">Can targeting the immune system using a combination therapy be a good strategy to slow Alzheimer’s disease progression? </b>
Funder: Alzheimer's Association
Funding type: research
Funder scheme: PTC
Start date: 2026-01-01
Investigator: Alireza Faridar
Institution: The Methodist Hospital Research Institute
Funded outputs count: 0
Funder award ID: PTC-26-1544195
OpenAlex ID: G6531378574